Ozarium (Losartan Potassium)

Losartan potassium, the active ingredient in Ozarium, is an angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It is used to manage hypertension and protect kidney function in certain patients. GNH USA supplies Ozarium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Ozarium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Losartan potassium is an ARB that modulates the renin‑angiotensin system to control blood pressure and related conditions.

- Hypertension: helps lower elevated blood pressure and reduce cardiovascular risk. - Diabetic nephropathy: slows progression of kidney damage in patients with type 2 diabetes. - Heart failure: assists in managing symptoms and improving outcomes in certain heart‑failure patients.

Losartan potassium may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dizziness - Headache - Fatigue - Nasal congestion - Upper respiratory tract infection - Diarrhea

Serious or Rare Side Effects: - Hyperkalemia - Acute kidney injury - Angio‑edema - Severe hypotension - Liver enzyme elevation - Myocardial infarction in rare cases

When prescribing Losartan potassium, clinicians should consider several safety aspects.

- Blood pressure monitoring: ensure adequate control and avoid excessive drops. - Renal function assessment: evaluate baseline kidney function and monitor periodically. - Electrolyte balance: check serum potassium, especially in patients on potassium‑sparing diuretics. - Pregnancy: avoid use in the second and third trimesters due to fetal toxicity. - Drug‑specific contraindications: review patient history for known hypersensitivity. - Store at below 25°C: keep in the original packaging, protect from moisture and light.

Lostablet interacts with several medicines that can alter its efficacy or safety profile.

Major Interactions (Avoid): - Potassium‑rich supplements or salts: may cause dangerous hyper‑kalemia. - Aliskiren (in diabetic patients): combined use can increase risk of renal impairment. - Strong CYP3A4 inhibitors (e.g., itraconazole): may raise losartan levels.

Moderate Interactions (Monitor Closely): - Diuretics (especially thiazides): can enhance hypotensive effect. - NSAIDs: may blunt antihy‑hypertensive response and affect renal function. - Lithium: concurrent use can increase lithium concentrations.